Clinical Trials Directory

Trials / Unknown

UnknownNCT04504656

Comparison of Early Outcomes of Minimally Invasive Surgery for Oesophageal Replacement Versus Open Surgery in Children

Status
Unknown
Phase
Study type
Observational
Enrollment
20 (estimated)
Sponsor
Assiut University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

a comparative prospective study of postoperative between minimally invasive and open surgery complications for esophageal replacement in children

Detailed description

Esophageal replacement in childhood is indicated in esophageal atresia patients with long-gap defects or following complications of primary esophageal anastomosis, as well as in patients with trauma and scarring to the esophagus following caustic ingestion. It is widely accepted that the ideal esophageal replacement is one that resembles the function of the native esophagus with minimal deterioration over time. Several techniques of esophageal replacement have been developed. These have focused mainly on the use of native tissues (including the stomach, jejunum, and colon) as conduits (1), attempts to use a synthetic prosthesis have been largely unsuccessful. In an attempt to reduce the trauma and morbidity associated with laparotomy and thoracotomy incisions, minimally invasive techniques are increasingly used. (2-4). Meta-analyses of adult esophagectomy for the treatment of esophageal cancer support the use of minimally invasive surgery (5) however, equivalent comparative studies in the pediatric population are lacking. As such, it is unclear whether minimally esophageal replacement is as safe as the open procedure in children. The present study aims to address this question by comparing the postoperative outcomes of children who underwent minimally invasive versus open esophageal replacement procedures at single-center and multicenter levels.

Conditions

Interventions

TypeNameDescription
OTHERobservation of postoperative leak, stenosis, mortalitydetect complications in both groups

Timeline

Start date
2020-03-01
Primary completion
2022-03-01
Completion
2022-10-01
First posted
2020-08-07
Last updated
2020-08-07

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT04504656. Inclusion in this directory is not an endorsement.